Answers are grounded in this paper and cite their sources.
insertion studies confirmed consistent membrane penetration with minimal invasiveness. Permeation study demonstrated efficient allergen transport (80-90%) across rat skin from coated MNs. In rats, a significant (p < 0.05) elevation in IgE (immunoglobulin E) titres following MN mediated delivery of PN (1.78-fold) and PS (1.39-fold) loaded PLGA matrices was recorded by day 50. These findings established EHDA-processed nut-PLGA coated MNs as a potentially promising platform for transdermal food allergen immunotherapy, enabling controlled release, effective skin permeation and preserved immunogenicity. The ability to coat allergen-formulations in minute and scalable quantities provides an opportunity to personalise specific food therapies using transdermal MNs.
No takes yet. Share an insight, caveat, or question.
Akhtar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: